Literature DB >> 34481090

Novel insertion mutation (Arg1822_Glu1823dup) in MYH6 coiled-coil domain causing familial atrial septal defect.

Shufang Huang1, Yueheng Wu2, Shaoxian Chen2, Yongchao Yang3, Yonghua Wang1, Haiping Wang1, Ping Li1, Jian Zhuang3, Yu Xia4.   

Abstract

OBJECTIVE: Atrial septal defect, secundum (ASD Ⅱ, OMIM: 603642) is the second common congenital heart defect (CHD) in China. However, the genetic etiology of familial ASD II remains elusive. METHODS AND
RESULTS: Using whole-exome sequencing (WES) and Sanger sequencing, we identified a novel myosin heavy chain 6 (MYH6) gene insertion variation, NM_002471.3: c.5465_5470dup (Arg1822_Glu1823dup), in a large Chinese Han family with ASD II. The variant Arg1822_Glu1823dup co-segregated with the disease in this family with autosomal dominant inheritance. The insertion variant located in the coiled-coil domain of the MYH6 protein, which is highly conserved across homologous myosin proteins and species. In transfected myoblast C2C12 cell lines, the MYH6 Arg1822_Glu1823dup variant significantly impaired myofibril formation and increased apoptosis but did not significantly reduce cell viability. Furthermore, molecular simulations revealed that the Arg1822_Glu1823dup variant impaired the myosin α-helix, increasing the stability of the coiled-coil myosin dimer, suggesting that this variant has an effect on the coiled-coil domain self-aggregation. These findings indicate that Arg1822_Glu1823dup variant plays a crucial role in the pathogenesis of ASD II.
CONCLUSION: Our findings expand the spectrum of MYH6 variations associated with familial ASD II and may provide a molecular basis in genetic counseling and prenatal diagnosis for this Chinses family.
Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Apoptosis; Atrial septal defect; MYH6; Myofibril formation; Whole exome sequencing

Mesh:

Substances:

Year:  2021        PMID: 34481090     DOI: 10.1016/j.ejmg.2021.104314

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  4 in total

1.  A Novel Splicing Mutation c.335-1 G > A in the Cardiac Transcription Factor NKX2-5 Leads to Familial Atrial Septal Defect Through miR-19 and PYK2.

Authors:  Li Jia; Dai Limeng; Tan Xiaoyin; Wang Junwen; Zhu Xintong; Xiong Gang; Bai Yun; Guo Hong
Journal:  Stem Cell Rev Rep       Date:  2022-07-02       Impact factor: 5.739

2.  Significance of α-Myosin Heavy Chain (MYH6) Variants in Hypoplastic Left Heart Syndrome and Related Cardiovascular Diseases.

Authors:  Melissa Anfinson; Robert H Fitts; John W Lough; Jeanne M James; Pippa M Simpson; Stephanie S Handler; Michael E Mitchell; Aoy Tomita-Mitchell
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-03

3.  A novel KLF13 mutation underlying congenital patent ductus arteriosus and ventricular septal defect, as well as bicuspid aortic valve.

Authors:  Pradhan Abhinav; Gao-Feng Zhang; Cui-Mei Zhao; Ying-Jia Xu; Juan Wang; Yi-Qing Yang
Journal:  Exp Ther Med       Date:  2022-03-01       Impact factor: 2.447

4.  Identification and functional analysis of variants of MYH6 gene promoter in isolated ventricular septal defects.

Authors:  Ji-Yang Zuo; Huan-Xin Chen; Zhi-Gang Liu; Qin Yang; Guo-Wei He
Journal:  BMC Med Genomics       Date:  2022-10-08       Impact factor: 3.622

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.